Becerra, C., Stephenson, J., Jonker, D. J., Cohn, A. L., Asmis, T. R., Bekaii-Saab, T. S., … Li, C. (2015). Phase Ib/II study of cancer stem cell (CSC) inhibitor BBI608 combined with paclitaxel in advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma. In Journal of Clinical Oncology (Vol. 33, pp. 4069–4069). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.4069

Becerra, Carlos, Joe Stephenson, Derek J. Jonker, Allen Lee Cohn, Timothy R. Asmis, Tanios S. Bekaii-Saab, Paul R. Conkling, et al. “Phase Ib/II study of cancer stem cell (CSC) inhibitor BBI608 combined with paclitaxel in advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma.” In Journal of Clinical Oncology, 33:4069–4069. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.4069.

Becerra C, Stephenson J, Jonker DJ, Cohn AL, Asmis TR, Bekaii-Saab TS, et al. Phase Ib/II study of cancer stem cell (CSC) inhibitor BBI608 combined with paclitaxel in advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 4069–4069.

Becerra, Carlos, et al. “Phase Ib/II study of cancer stem cell (CSC) inhibitor BBI608 combined with paclitaxel in advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 4069–4069. Crossref, doi:10.1200/jco.2015.33.15_suppl.4069.

Becerra C, Stephenson J, Jonker DJ, Cohn AL, Asmis TR, Bekaii-Saab TS, Conkling PR, Garbo LE, Lenz H-J, Richards DA, Spira AI, Mikhail S, Goodwin RA, Yoon HH, Hume S, Hitron M, Li C. Phase Ib/II study of cancer stem cell (CSC) inhibitor BBI608 combined with paclitaxel in advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 4069–4069.